NIH-funded trials often miss diversity targets, small study shows
Despite increased urgency to diversify clinical trials, a majority of NIH-funded trials that had completed enrollment in a recent study missed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
